Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract

Eric S Wang1, Elena Dobrikova, Christian Goetz

  • 1Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Journal of Virology
|April 1, 2011
PubMed

Insights

Researchers developed a mouse model for enterovirus (EV) respiratory infections. This breakthrough allows studying common cold mechanisms and testing antiviral treatments in vivo.

Area of Science:

  • Virology
  • Respiratory Medicine
  • Immunology

Background:

  • Enteroviruses (EVs) cause common colds and worsen chronic lung diseases.
  • Lack of small-animal models hinders understanding EV respiratory infections and antiviral testing.

Purpose of the Study:

  • To develop a practical small-animal model for studying enterovirus respiratory tract infections.
  • To investigate enterovirus adaptation and host interactions within the respiratory tract.

Main Methods:

  • Serial passage of coxsackievirus A21 in the lungs of mice genetically engineered to express human ICAM-1 (hICAM-1).
  • Analysis of viral genome changes during adaptation to the mouse respiratory tract.

Main Results:

  • Evolution of variant coxsackievirus A21 capable of replication in the mouse respiratory tract.
  • Identification of viral genome alterations indicating adaptation to the specific conditions of the respiratory tract.

Conclusions:

  • A mouse model for enterovirus respiratory infections using hICAM-1 transgenic mice has been established.
  • This model provides a platform for studying enterovirus-host interactions and evaluating antiviral strategies in vivo.